Skip to content
Home/Companies/Biotech/AAVantgarde Bio
AB

AAVantgarde Bio

Biotech·Italy·Active·6yr hold

AAVantgarde Bio is a healthcare / biotech company, headquartered in Italy.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns AAVantgarde Bio?

AAVantgarde Bio is currently owned by Sofinnova Partners through Sofinnova Telethon (2016 vintage), since 2020. Across its history, AAVantgarde Bio has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Telethon · 2016 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQItaly
SectorHealthcare / Biotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners and Athos since 2020.
Co-invest · 2 holders · 2020 · present
Sofinnova Partners
Sofinnova PartnersActive
2020 · present · Sofinnova Telethon · 2016 · Life Sciences VC
MOIC
–
Athos
AthosActive
2025 · present · Athos Evergreen Life Sciences · 2001 · Evergreen
MOIC
–

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)
Active
BiotechUS· 2022
Nephris
Active
BiotechItaly· 2022
Alia Therapeutics
Active
BiotechItaly· 2021
Borea Therapeutics
Active
BiotechItaly· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings